Insmed Incorporated
Insmed Incorporated (INSM) — Form 144: Proposed sale of shares
AI-generated summary
Former Officer Sara Bonstein filed a proposed sale of 10,261 common shares of Insmed Incorporated with an aggregate market value of $1,121,629 through Merrill Lynch. The shares were acquired through stock plan activity on October 30, 2026. The filing notes the shares were sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units and to cover related broker fees.
Key facts
- Seller
- Sara Bonstein
- Relationship
- Former Officer
- Shares to sell
- 10,261
- Market value
- $1,121,629.00
- Approximate sale date
- Nov 3, 2026
- Broker
- Merrill Lynch
- Acquired
- Oct 30, 2026 · Stock Plan Activity
Remarks
- Shares were sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units and to cover related broker fees
More INSM filings
- 3
Filed Nov 3, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.